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ABSTRACT 
This review article covers a concise account on fludeoxyglucose (
18F-FDG) synthesis and quality control procedures 
with emphasis on practical synthesis Currently, 
18F-FDG is the most successful PET radiopharmaceutical so far. The 
advancement in synthesis and quality control of 
18F-FDG, together with its approval by the US FDA and the availability 
of reimbursement, are probably the main reasons for the flourish of clinical PET over the last 20 years. 
18F-FDG can be 
synthesised by either electrophilic fluorination or nucleophilic fluorination reaction. Nucleophilic fluorination using 
mannose triflate as precursor and Kryptofix or tetrabutylammonium salts (TBA) is widely used because of higher yield 
and shorter reaction time. The quality control requirements of 
18F-FDG can be found in United States Pharmacopeia 
(USP), British Pharmacopeia (BP), European Pharmacopeia (EP) and the Chemistry, Manufacturing, and Controls 
(CMC) section from United States Food and Drug Administration (US FDA) PET draft guidance documents. Basic 
requirements include radionuclidic identity, radiochemical purity, chemical purity, pH, residual solvent, sterility, and 
bacterial endotoxin level. Some of these tests (sterility, endotoxins and radionuclidic purity) can be finished after the 
18F-FDG has been released. Although USP, BP and EP do not require filter membrane integrity test, many laboratories 
perform this test as an indirect evident of the product sterility. It is also interesting to note that there are major 
differences in 
18F-FDG quality requirements among USP, BP, and CMC. © 2006 Biomedical Imaging and Intervention 
Journal. All rights reserved. 
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INTRODUCTION 
18F-FDG is a glucose analogue in which the 
hydroxyl group on the 2-carbon of a glucose molecule is 
replaced by a fluoride atom. Like glucose, 
18F-FDG is 
taken up into living cells by facilitated transport and then 
phosphorylated by hexokinase. Unlike glucose, 
18F-FDG 
cannot undergo further metabolism because the hydroxyl 
group at the 2-carbon is a requirement for the process 
[1-2]. Nevertheless, 
18F-FDG is a good indicator of 
glucose uptake and cell viability.  
The uptake of glucose analogues into living cells 
also depends on modifications of various carbons at 
different positions. It has been shown that the specificity 
of 3-deoxyglucose (3-DG) and 4 deoxyglucose (4-DG) 
towards hexokinase reduced by 100-fold [3], hence 
3-DG and 4-DG were not retained inside the cells. 
Similarly, 3-fluoro-deoxyglucose and 4-fluoro-
deoxyglucose do not accumulate in living cells as much 
as 
18F-FDG. Although the nucleophilic substitution 
reaction is more widely used nowadays, the electrophilic 
 
 * Corresponding author. Present address: Departments of Nuclear
Medicine & PET and Experimental Surgery, Singapore General
Hospital, Outram Road, Singapore. Tel.: +(65) 6326-5666; E-mail: 
sdnyyu@yahoo.com.sg (Sidney Yu). S Yu. Biomed Imaging Interv J 2006; 2(4):e57    
    This page number is not 
    for citation purpose 
 
fluorination reaction has an important place in the 
synthesis of 
18F-FDG. 
SYNTHESIS OF 
18F-FDG BY ELECTROPHILIC 
FLUORINATION 
The first synthesis of 
18F-FDG was carried out in 
Brookhaven National Laboratory by Wolf et al. in 1976 
by electrophilic fluroination [4]. As shown in Figure 1, 
electrophilic fluorination refers to the addition of fluorine 
atoms across a double bond, producing a difluoro 
derivative of the parent compound. The electrophilic 
fluorination by Wolf et al. involved the use of 3, 
4,6-tri-O-acetyl-D-glucal as precursor. The glucal was 
treated with 
18F-F2 to produce a 3:1 mixture of 
18F 
labelled difluoro-glucose and difluoro-mannose 
derivatives. The difluoro-glucose derivative was 
separated and hydrolysed with hydrochloric acid to form 
2-fluoro-2-deoxyglucose (Figure 2). The yield was 8% 
and the synthesis time was 2 hours [4]. 
Despite the low yield and long synthesis time, the 
Brookhaven team was able to collaborate with The 
Hospital of the University of Pennsylvania to map 
glucose metabolism in human brain [4]. This was the 
first 
18F-FDG trial in human. 
Several improvements to the electrophilic 
fluorination described above were made thereafter. One 
of the most useful modifications was the use of 
acetylhypofluorite 
18F-CH3CO2F. The acetylhypofluorite 
can be produced in situ from 
18F-F2. The yield was 
higher and the synthesis reaction was easier to control 
[4-6 ].  
The major limitation of electrophilic fluorination 
was that only 50% of the radioactive fluorine atoms were 
incorporated into the precursors. In addition, the 
18F-F2 
was produced from a Neon gas target with 0.1% to 1% of 
fluorine gas via a 
20Ne(d,α)
18F reaction. The specific 
activity is lower due to the presence of the 
non-radioactive fluorine gas. The maintenance and 
operation of a Neon target is troublesome and the yield 
of 
18F
- was much lower than with the 
20Ne(d,α)
18F 
reaction than with the 
18O(p,n)
18F
- reaction. [4, 7-8]  
SYNTHESIS OF 
18F-FDG BY NUCLEOPHILIC 
FLUORINATION 
Many attempts have been made to develop a 
nucleophilic substitution for the synthesis of 
18F-FDG. 
This included the use of 
18F-CsF, 
18F-Et4NF, and 
18F-KHF [4, 9-14]. But the major breakthrough was 
reported in 1986 by Hamacher et al. who had used 
Kryptofix 222
TM as a catalyst [15]. The reaction had a 
consistent yield of over 50% and the reaction time was 
shortened to 50 min.  
Nucleophilic substitution is a chemical reaction 
involving the addition of a nucleophilic molecule (highly 
negatively charged molecule) into a molecule with a 
leaving group (electron drawing group attached to the 
parent molecule through an unstable chemical bond). 
Figure 3 is a general scheme for an SN2 nucleophilic 
substitution reaction. The nucleophilic molecule has a 
high affinity towards the relatively electron deficient 
centre in the parent molecule created by the electron 
pulling leaving group. As a result, the nucleophilic 
molecule forms a covalent bond with the parent molecule 
and displaces the leaving group. The stereo-configuration 
of the parent molecule is also changed. 
In the synthesis of 
18F-FDG, 
18F ion is the 
nucleophile. The precursor is mannose triflate in which 
the 1,3,4,6 position carbons of a mannose moleucle are 
protected with an acetyl group and triflate is the leaving 
group at the 2-carbon. In the presence of Kryptofix 
222
TM as catalyst and acetonitrile as solvent, 
18F ion 
approaches the mannose triflate at the 2-carbon, while 
the triflate group leaves the protected mannose molecule 
to form 
18F-FDG (Figure 4). 
Although synthesis of 
18F-FDG can be carried out in 
different computer controlled automatic synthesizers, the 
nucleophilic process proceeds in roughly same stages: 
Removal of 
18F from the 
18O
- water coming out from the 
cyclotron target 
Fluorine has a high hydration energy, so water is not 
a suitable solvent in this synthesis. Polar aprotic solvent 
such as acetonitile should be used in an SN2 nucleophilic 
substitution reaction. Since 
18F
- is produced by a 
18O(p,n)
18F
- reaction, it is necessary to isolate the 
18F ion 
from its aqueous environment. The most convenient way 
to isolate is to use a light QMA (Quaternary ammonium 
anion exchange) Sep-Pak column (Accell Plus QMA 
Sep-Pak
TM). The 
18F
- is retained by or via an 
ion-exchange reaction and allowed the 
18O-water to flow 
through. The retained 
18F
- is then eluted with an 
acetonitrile solution of Kryptofix and potassium 
carbonate (Figure 5). 
In an aqueous environment, any negatively charged 
ions must be accompanied by positively charged 
counterparts. Usually, the 
18F
– washed out from the 
cyclotron target is accompanied by traces of metal ions 
from the surface of the target body. When passing 
through the light QMA anion exchange ion, the 
18F 
– is 
retained and the metal ions will be lost in the 
18O
- water. 
Hence, it is necessary to introduce a positively charged 
counter ion to restore the 
18F
– reactivity before 
evaporation of residual 
18O
- enriched water [16].  
Several types of positively charged counter ions 
have been used, including large metal ions such as 
rubidium or caesium; potassium ion complexed by a 
large ring structure such as Kryptofix 222
TM  and 
tetrabutylammonium salts [16-17]. Kryptofix 222
TM is a 
cyclic crown ether (Figure 6), which binds the potassium 
ion, preventing the formation of 
18F-KF. Thus, potassium 
acts as the counter ion of 
18F
- to enhance its reactivity but 
does not interfere with the synthesis.  
Since Kryptofix 222
TM  causes apnoea and 
convulsion, all automatic synthesis modules have 
multiple removal steps so that there is only negligible 
amount of Kryptofix in the final 
18F-FDG products. 
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Figure 1  Electrophilic fluorination. 
 
 
 
 
 
 
 
 
 
Figure 2  Synthesis of 18F-FDG by electrophilic fluorination. 
 
 
 
 
 
 
 
 
Figure 3  Nucleophilic substitution: Nu = nucleophilic molecule, X = leaving group. 
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Figure 4  Synthesis of 
18F-FDG by nucleophilic substitution. 
 
 
 
 
 
 
 
 
 
Figure 5  (a) Retention of 18F-FDG in light QMA ion exchange column; (b) elution of 18F from light QMA ion 
exchange column. 
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Tetrabutylammonium salts (TBA) are also widely used 
as catalyst in place of Kryptofix 222
TM [18].  
Logically, the addition of a counter cation also 
includes the addition of another anion. The carbonate 
anion is most widely used because it is less likely to 
interfere with the synthesis [16].  
Evaporation of residual 
18O
- water from the 
18F with 
acetonitrile 
After the 
18F
- is eluted into reaction vessel, it is 
necessary to evaporate any residual water from the 
solution. The advantage of using acetonitrile as the 
eluting solvent is that it forms an azeotropic mixture with 
water. Evaporation of the acetonitrile in a nitrogen 
atmosphere will at the same time remove any residual 
18O
- water escaped into the reaction vessel together with 
the 
18F .  M o s t  o f  t h e  
18F-FDG automatic synthesizers 
perform the acetonitrile evaporation step several times to 
ensure all the residual 
18O
-  water is removed. All 
components of the synthesis system are also rinsed with 
acetonitrile to remove moisture. Dry nitrogen (moisture 
content less than 3 ppm) should be used in the synthesis  
Addition of mannose triflate into the 
18F
- with 
acetonitrile 
The nucleophilic substitution takes place in this 
stage. After the evaporation of any residual water, the 
precursor is added to the 
18F
-. The choice of precursor 
depends on the ease of preparation, ease of producing the 
final product, consistency, yields, and so on. The most 
commonly used precursor molecule in synthesis of 
18F-FDG is 1,3,4,6-O-Acetyl-2-O-trifluoro-
methanesulfonyl-beta-D-mannopyranose (mannose 
triflate). Its structure (Figure 7) is similar to that of FDG, 
except with a triflate group at the 2 carbon position and 
acetyl groups at 1,3,4,6 position carbons via ester bonds, 
which can be readily broken at a higher or lower pH. The 
use of acetyl groups is to protect the hydroxy groups so 
that fluorination would not occur at these positions. The 
18F ion approaches the mannose triflate at the 2 position 
carbon, while the triflate group leaves the protected 
mannose molecule to form 
18F-FDG (Figure 4). After the 
nucleophilic replacement of the triflate group by 
18F
-, the 
acetyl groups can be easily removed by hydrolysis to 
give rise to 
18F-FDG 
The choice of leaving a group is an important 
consideration. A good leaving group should have the 
properties of leaving the parent molecule readily. Once it 
departs from the parent molecule, its negative charge is 
stabilised by delocalisation and it will not re-enter the 
parent molecule.  
Commonly available leaving groups include triflates, 
tosylates, and mesylates, among others. The choice of 
leaving a group depends on the nature of the reaction, the 
solvent, the stability of the precursor, and so on. All of 
the leaving groups listed in Table 1 except chlorides have 
been used in radio-fluorination reactions. In the synthesis 
of 
18F-FDG, triflates produces a higher and more 
consistent yield at about 50 to 60% [16].  
Hydrolysis to remove the protective acetyl groups to 
form 
18F-FDG 
The final step of the synthesis is to remove the 
protective acetyl groups on the 1,3,4,6 position carbons. 
This can be accomplished by either using hydrochloric 
acid (acid hydrolysis) or sodium hydroxide (base 
hydrolysis). Acid hydrolysis requires a longer time and 
higher temperature. Base hydrolysis, which is more 
commonly used currently, is faster and takes place at 
room temperature. One of the improved base hydrolysis 
is to adsorb the 1,3,4,6 acetyl protected 
18F labelled 2 
deoxyglucose on to a C-18 reverse phase column. All 
other impurities can be removed by rinsing heavily with 
water. Sodium hydroxide is added to the column so that 
the base hydrolysis occurs on the column surface. The 
final 
18F-FDG product can be eluted with water while the 
unhydrolysed or partially hydrolysed 1,3,4,6 acetyl 
protected 
18F labelled 2 deoxyglucose remains on the 
column [19]. 
Purification of the final 
18F-FDG product 
Purification of the final 
18F-FDG can be performed 
with a series of anion exchange column, C-18 reverse 
phase column and alumina column. Most automatic 
synthesizers can produce 
18F-FDG of over 95% routinely. 
QUALITY CONTROL OF 
18F-FDG 
The quality requirements of 
18F-FDG are set out in 
various pharmacopoeia including the USP [20], BP [21], 
EP [22], etc. The US FDA has also published a draft 
Chemistry, Manufacturing and Controls (CMC) 
document concerning 
18F-FDG [23]. It should be noted 
that the quality control requirements of 
18F-FDG differ 
among these references. An excellent comparison 
between them can be found elsewhere [24]. In Asia, 
Taiwan has established an official guideline for the 
compounding of PET drug products, as well as for the 
quality control of 
18F-FDG.  
Different countries my adopt a different set of 
standards. The BP is described in this article solely 
because this is the standard adopted by the author’s 
country. Table 2 lists the quality control tests required by 
BP [21]. Due to short half-life of 
18F-FDG, not all the 
listed tests can be completed before release of the 
18F-FDG product. The BP allows the 
18F-FDG to be 
released before the radionuclidic purity test, bacterial 
endotoxin test, and sterility test are finished. 
There are other tests not listed in the BP, but may be 
of significance. The BP does not list a test for ethanol, 
which is widely used in the synthesis of 
18F-FDG. Both 
USP and BP do not list the membrane filter integrity test. 
However, the test is essential as an indirect evidence of 
the 
18F-FDG product sterility because the sterility test 
result will not be available until much later. 
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Figure 6  Kryptofix 222 ™ and K
+. 
 
 
 
 
 
 
 
 
Figure 7  Structures of mannose triflate and 
18F-FDG. 
 
 
 
 
 
 
    
(a)                                                                                                      (b) 
Figure 8  (a) Filter membrane is intact, no air passes through the membrane, no air bubble in water; (b) Filter 
membrane is broken or at bubble point, air passes through the membrane, air bubble in water. The 
bubble point should be higher than or equal to maximum pressure listed in the specification of the filter. 
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Character 
Although the BP does not specify the test method, it 
is obvious that a visual inspection of the 
18F-FDG is 
implied. The product should be observed behind 
adequate shielding. While BP allows a slightly yellow 
colour, this may indicate the presence of impurities. An 
18F-FDG product should only be clear and colourless. 
Identity (radionuclidic and radiochemical) 
In BP, the tests for radionuclidic identity and 
radiochemical identity are the same tests for 
radionuclidic purity and radiochemical purity. The 
radionuclidic identity can be confirmed either by 
obtaining a gamma spectrum or measuring the half life of 
the product. However, the photon energy of 0.511 MeV 
and the sum peak at 1.022 MeV are common features to 
positron emitters. Hence, obtaining a gamma spectrum 
may not be adequate in confirming the presence of 
18F
- [24].  
Measurement of the half-life can be carried out by 
measuring the same test solution in the same dose 
calibrator at 2 or more time points. The half-life is then 
calculated by plugging the results into the radioactivity 
decay equation. The BP does not specify the time 
interval between each measurement, but it should be long 
enough to allow a significant decay. The author suggests 
a minimum decay period of of 20 to 30 min. Other 
experts have established that a minimum of 10 min is 
necessary [24]. The measurement of half-life is a more 
reliable method in confirming the presence of 
18F
-. 
In BP, the radiochemical identity can be confirmed 
either by HPLC or TLC. The TLC is easier, but as 
accurate and reliable as the HPLC. However, TLC may 
take longer time. For the test of 
18F-FDG, the TLC 
stationary phase is TLC-SG and the mobile phase is 
acetonitrile : water (95%:5% v/v). The Rf of the 
18F-FDG, 
free 
18F
-, and acetylated 
18F-FDG are abut 0.45, 0.0 and 
0.8 to 0.95 respectively. It should be noted that TLC 
results can vary according to different brands of TLC 
plates and operation conditions. It is therefore important 
to use the same brand of TLC-SG plate and freshly 
prepared mobile phase if possible. When plates with a 
new batch number (from the same brand) are used, the 
Rf values should be confirmed as per the validation 
process. The spotting technique also has significant 
effects on the TLC results. The spot size should be about 
2 to 5 µL. It should be dried and placed above the mobile 
phase level. 
pH 
The pH value of an injectable should be as close to 
the physiological pH as possible. The BP does not 
specify a method for testing the pH of the 
18F-FDG. 
Some laboratories would use pH papers while others 
would use pH meters. It should be noted that the pH 
paper used should be verified with standard pH buffers, 
display a colour change for each 0.5 pH unit, and the pH 
value measured using pH paper is only an approximate 
[24]  
Chemical purity 
The BP specifies the chemical purity FDG and 
2-chloro-deoxyglucose (for acid hydrolysis synthesis 
only) to be determined by HPLC with a strong basic 
anion exchange column. The author has used a 
Carbopac™ column with good results, however, other 
commercially available strong basic anion exchange 
columns can perform equally well. The mobile phase is 
0.1M NaOH and the flow rate is 1ml/min. Since NaOH 
absorbs carbon dioxide from air readily, it should be 
protected from air, stored in plastic containers and 
freshly prepared if possible. The Carbopac™ column is 
also very sensitive to carbonate ions. This adds to the 
importance of protecting the NaOH from air.  
The test protocol includes injecting and run the 
HPLC of a reference standard solution and then run the 
HPLC of the test solution. The acceptance criteria is the 
area under the FDG peak of the test solution should be 
less than that of the reference solution. In theory, the 
reference material used should be of pharmacopoeia 
grade. The USP has listed three USP grade FDG 
reference standards, but so far it has not been available 
commercially. One can only obtain non pharmacopoeia 
grade FDG or 2-chloro-deoxyglucose from commercial 
vendors for preparation of reference solutions. 
It is interesting to note that the BP states the 
preparation of glucose reference solution in addition to 
FDG and 2-chloro-deoxyglucose but does not require the 
reporting of glucose quantity presence in an 
18F-FDG 
product.  
The test of Kryptofix involves spotting the test 
solution and the reference standard on a TLC-SG plate 
and then develop the plate in a mixture of methanol and 
ammonia (9:1 v/v). The developed plate is then exposed 
to iodine vapour. The test solution spot should have a 
colour lighter than the reference solution spot. However, 
this TLC method is unreliable. The spots can be 
indistinct [24]. Alternatively, Kryptofix can be 
determined by placing the TLC plate in an iodine 
chamber directly or by GC [25]. 
Residual solvent 
The BP lists only the determination of residual 
acetonitrile in the 
18F-FDG product. But the BP does not 
specify the test method, although the description implies 
that a GC should be used.. The GC column should be 
used for aqueous solvent and the oven temperature 
should be constant. A flame ionisation detector is 
adequate. The actual temperature, carrier gas flow rate, 
and run time vary among different laboratories. 
The BP does not mention any test of residual 
absolute ethanol. Since absolute ethanol is widely used in 
deferent 
18F-FDG synthesis modules and GC test takes 
only a few minutes, it is better to measure the residual 
absolute ethanol concentration in the 
18F-FDG product. 
Many laboratories adopt the USP limits of 0.05% or 
5mg/mL 
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Radionuclidic purity 
The BP lists recording gamma spectrum and 
measuring half-life as two methods to determine the 
radionuclidic purity of a 
18F-FDG product. Measurement 
of half-life can only confirm the presence of 
18F. It does 
not reveal the percentage purity of the 
18F
- present. The 
more accurate method is to obtain a gamma spectrum 
with a multi-channel analyzer after confirmation of 
18F
- by measuring its half-life The BP allows the 
18F-FDG to be released before the completion of this test. 
Some experts doubt the necessity of carrying out a 
radionuclidic purity determination since its outcome is 
not crucial to patient welfare and imagine quality[24]. In 
fact, many laboratories measure the half-life of their 
18F-FDG, but they do not obtain gamma spectra of their 
18F-FDG products routinely. 
Radiochemical purity 
The BP lists both HPLC method and TLC method 
for the determination of radiochemical purity. The 
method has been described in radiochemical identity 
under section “(2) Identity (radionuclidic and 
radiochemical)”  
Sterility 
Sterility is to be tested by incubating the test sample 
with both Soybean Casein Digest Medium(SCDM) and 
Fluid Thioglycollate (FTM) Medium for 14 days at 37°C. 
Soybean Casein Digest Medium is a culture media for 
aerobic bacteria and fungi while FTM is a media for 
anaerobic bacteria. Growth Promotion Tests should be 
performed simultaneously. This test is performed by 
incubating “reference bacteria” in SCDM and FTM. 
Bacterial growth should be visible within a specified 
period of incubation (Table 3). Results of the growth 
promotion would indicate that the SCDM and FTM are 
capable of supporting bacterial growth, hence results of 
the sterility test are reliable. However, the US FDA has 
recommended a 30-hr window for 
18F-FDG within which 
the sterility test must be started. 
Most PET facility would forward their samples to 
other microbiology laboratories for sterility test. A 
period of decay is necessary to ensure that the 
radioactivity level is not excessive. In many cases, a 
24-hr window may not be long enough. Individual 
laboratories should establish their own protocols in this 
matter. 
Bacterial endotoxins (LAL test) 
The bacterial endotoxins level is commonly tested 
using the gel-clot technique. The technique uses a lysate 
of amoebocytes from horseshoe crab, Limulus 
polyphemus. The addition of bacterial endotoxins to a 
lysate solution produces turbidity, precipitation or 
gelation of the mixture. Most commercially available 
endotoxin testing kits require an incubation period of 20 
to 60 min. Hence, it is unlikely that the test can be 
completed before release of the product. The BP allows 
the release of the 
18F-FDG before completion of the 
bacterial endotoxins test. Some PET facility would 
forward their samples to other microbiology laboratories 
for endotoxins test. As described earlier, a period of 
decay is necessary to ensure that the radioactivity level is 
not excessive. 
Bacterial endotoxins level can also be determined by 
spectrophotmetry. The chromogenic method makes use 
of the colour change of a substrate produced by the 
formation of an enzyme which in turn results from the 
addition of endotoxins to Limulus polyphemus lysate. 
Gram-negative bacterial endotoxins have been found to 
activate a proenzyme in Limulus polyphemus lysate. The 
rate of this activation reaction depends on the 
concentration of the endotoxins present. The activated 
proenzyme then catalyses the spitting of substrates added. 
The splitting of the substrates results in a colour change 
which can be monitored by spectrophotometry. Then 
time required for the appearance of the colour change is 
inversely proportional to the endotoxins concentration 
present. Hence, the endotoxins concentration can be 
determined by comparing the reaction time of a sample 
to a standard curve generated from a series of standards 
containing known concentrations of endotoxins [26, 27]. 
 
The endotoxins concentration in a sample can also 
be determined by measuring the turbidity change during 
the gel-clot formation using spectrophotometry. The time 
for onset of turbity is inversely related to the endotoxin 
concentration present. Endotoxin level in unknown 
sample can be determined by comparing the time 
required for turbidity onset to a standard curve generated 
from a series of standards with known endotoxins 
concentrations [28]. However, such method is extremely 
sensitive to interference from polysaccharide such as 
β-Glucans. Improved methods have been developed to 
reduce such interference [29].  
Filter membrane integrity test 
This test is not required by BP and USP, but is 
required in the CMC section of US FDA [23]. Many 
laboratories have also included this test as one of their 
routine quality control tests of 
18F-FDG. 
Since the 
18F-FDG is released and injected into 
patients before the sterility results are available, there is 
virtually no assurance of the product sterility. Filter 
membrane integrity test provide an indirect evident that 
the product is sterile. The argument is that if the integrity 
of the filter membrane is not compromised, the filter 
would have performed its function of removing any 
bacteria present in the 
18F-FDG product. 
A few filter membrane integrity testing devices are 
available commercially. Some of them rather 
complicated and some of them are simple hand-held 
types. The mechanisms behind them are similar. A 
Proenzyme + 
endotoxins 
Substrate added 
into the sample 
enzyme 
colour change of 
the substrate 
8 S Yu. Biomed Imaging Interv J 2006; 2(4):e57    
    This page number is not 
    for citation purpose 
 
stream of air is passed through the devices to the filter, 
then to a reservoir of water. An indicator will show the 
pressure exerted on the filter membrane by the air stream. 
The filter membrane should be able to stand the 
maximum pressure indicated in the specification of the 
filter. If the membrane is broken the air stream will pass 
through the membrane into the water. Air bubble will 
then be seen (Figure 8). 
The biggest disadvantage of performing filter 
membrane integrity test is that usually the filter 
membranes are highly radioactive immediately after 
production of 
18F-FDG. But allowing a 24-hr decay 
would defeat the purpose of providing an evident of 
sterility before injecting the 
18F-FDG. Individual 
laboratories would have to develop their own protocols 
in this matter.  
CONCLUSION 
Much of the current success in clinical PET can be 
attributed to the development of 
18F-FDG. Synthesis of 
18F-FDG is probably the most repeatable and highest 
yield in all PET radiopharmaceuticals synthesis. 
However, the future of PET would depend on the 
upcoming of new radiopharmaceuticals and the 
regulatory framework for the usage and approval of new 
PET drug products (e.g. NDA, IND etc). Synthesis, 
quality control and regulation of 
18F-FDG become a 
model in the development new PET 
radiopharmaceuticals. Nucleophilic and electrophilic 
fluorinations are very common reactions to label 
compounds with 
18F. The concept of using automatic 
synthesis modules is now a platform in PET 
radiopharmaceuticals synthesis. It is hope that this article 
will provide a brief review of 
18F-FDG synthesis and 
quality control for those who are interested in 
development of PET radiopharmaceuticals. However, 
this article is only a concise review and not complete. 
Interested readers are encouraged to seek more detailed 
information 
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Table 1  A comparison of various leaving groups 
Leaving group Properties 
Trifates  very good leaving group 
Toyslate  
Mesylate  
Iodide  moderate leaving group 
Bromide  
Chloride  poor leaving group 
 
 
 
Table 2  Quality control tests of 
18F-FDG listed in BP 
Test Method  Acceptance  Criteria 
Character Not  specified  Clear, colourless or slightly 
yellow liquid 
Identification  Gama- Gamma-spectrum  Photon energy of 0.511Mev or 
1.022MeV 
  Half-life measurement  105 to 115 min 
  Examine the chromatogram peak 
from radiochemical purity test 
The product should have the 
same retention time as the 
reference solution 
pH  Not specified  4.5 to 8.5 
Chemical Purity:     
  2-FDG  HPLC  The area of the 2-FDG peak is 
not greater than the area of the 
reference peak (10mg/maximum 
injected dose in mL)  
  Kryptofix  Colourimetirc  The test spot should not be darker 
than the reference spot 
  tetra-alky ammonium salt  HPLC  The area of the product peak is 
not greater that the area of the 
reference peak (2.75 mg / 
maximum injected dose in mL) 
Residual solvent:     
  Acetonitrile  Not specified  Less than 4.1mg per maximum 
dose volume injected 
Radionuclidic purity  Gama-spectrum  Photon energy of 0.511Mev or 
1.022MeV 
  measurement of half-life  105 to 115 min 
Radiochemical Purity  HPLC 
TLC 
Not less than 95% of the total 
radioactivity 
Sterility  Standard sterility test according to 
BP 
No bacterial growth 
Bacterial Endotoxin  Not specified   175 international unit/maximum 
dose in mL 
Radioactivity  Measurement in calibrated dose 
calibrator 
 ---- 
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Table 3  Test microorganisms listed in BP suitable for Growth Promotion test  
Microorganism Incubation 
Species Strain 
Incubation 
temperature 
Maximum duration within 
which bacterial growth is 
visible 
Aerobic bacteria:       
Staphylcoccus aureus  ATCC 6538 
CIP4.83 
NCTC 10788 
NCIMB 9518 
Bacillus subtilis  ATCC6633 
CIP52.62 
NCIMB 8054 
Pseudomonas aeruginosa  ATCC 9027 
NCIMB 8626 
CIP82.118 
30 to 35°C in FTM  3 days 
Anaerobic bacteria       
Clostridium sporogenes  ATCC 19404 
CIP79.3  30 to 35°C in SCDM  3 days 
Fungi      
Candida albicans  ATCC 10231 
IP48.72 
ATCC 2091  
IP1180.79 
Aspergillus niger  ATCC 16404 
30 to 35°C in FTM  5 days 
 
 
 
 
 
 
 
11 